Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$160.79−0.31 (-0.19%)
Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –
Novartis Total Assets: $117,149M in Q3 2026, up 9.2% from a year earlier.
Latest, Q3 2026
117,149
Period ended Sep 30, 2026
Change on a year earlier
+9.2%
107,289 in Q3 2025
History
35 quarters
Since Q4 2016
Sources
33
Documents cited below
Where the Q3 2026 figure comes from
“|| Total assets | 117 149 | 110 949”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Postgres DB + Form 6-K.
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up total Assets
- Total Current Assets28,747 · Q3 2026
- Cash & Cash Equivalents8,870 · Q3 2026
- Marketable Securities, Commodities & Short-Term Derivatives105 · Q3 2026
- Accounts Receivable9,780 · Q3 2026
- Inventory6,104 · Q3 2026
- Total Non-Current Assets88,402 · Q3 2026
- Property, Plant & Equipment10,622 · Q3 2026
- Operating Lease Assets1,649 · Q3 2026
- Goodwill27,175 · Q3 2026
- Intangible Assets39,827 · Q3 2026
- Deferred Tax Assets5,346 · Q3 2026
- Total Liabilities79,585 · Q3 2026
- Total Current Liabilities32,525 · Q3 2026
- Trade Payables4,243 · Q3 2026
- Short-Term Financial Debt & Current Portion Due Within 1 Year (current-debt)9,650 · Q3 2026
- Non-Current Financial Debts36,699 · Q3 2026
- Deferred Tax Liabilities4,397 · Q3 2026
- Total Equity37,564 · Q3 2026
- Shareholders' Equity37,228 · Q3 2026
- Treasury Stock-54 · Q3 2026
Cite this data
StockData. (2026). Novartis Total Assets ($M), quarterly Q4 2016–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-total-assets
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.